WHO Launched Tuberculosis Research Toolkit
The new online resource aims to improve the inclusion of pregnant and lactating women in clinical studies.
Updated on Oct. 13, 2026 in Asthma
Live Poll
Should medical research prioritize the inclusion of pregnant and breastfeeding women in clinical trials?
The World Health Organisation has released an online toolkit designed to support tuberculosis research involving pregnant and lactating women. This resource provides guidance for researchers on vaccine trials, pre-clinical studies, and pharmacokinetics.
Why it matters
Pregnant and lactating women have historically been underrepresented in tuberculosis research. These ongoing evidence gaps have delayed the development of medical innovations and access to optimal care for this specific demographic.
The toolkit provides structured guidance for tuberculosis research, including standardized trial design and pharmacokinetic protocols for pregnant and lactating individuals. Its implementation remains pending as research teams integrate these new considerations into future study designs.
The players
World Health Organisation
The World Health Organisation is a specialized agency of the United Nations responsible for international public health.
The details
The toolkit serves as a comprehensive online resource intended to streamline trial design and ensure proper evaluation of safety and efficacy for pregnant and lactating patients. It specifically covers essential components such as vaccine trial considerations and necessary pre-clinical trial methodologies.
Timeline
October 12, 2026: The World Health Organisation launched the research toolkit.
The Big Picture
This initiative follows the World Health Organisation's global tuberculosis strategy by addressing critical research barriers that previously hindered universal access to effective prevention and treatment. It marks a shift toward more inclusive clinical trial standards in infectious disease medicine.
By increasing the inclusion of pregnant and lactating women in research, this toolkit aims to provide clearer medical data that will eventually guide safer treatment choices. Patients may see improved care protocols as clinicians receive more accurate information regarding drug efficacy and safety in these populations.
The takeaway
Standardizing research protocols for pregnant and lactating women is essential for closing long-standing healthcare disparities. Researchers and health practitioners should prioritize incorporating these new guidelines to ensure medical interventions are safe and effective for all patients.
Further reading
For more information on respiratory health initiatives, visit our Asthma section.
Live Poll
Should medical research prioritize the inclusion of pregnant and breastfeeding women in clinical trials?
